Photo from wikipedia
Key Points Bendamustine with rituximab is a highly effective frontline therapy in extranodal marginal zone lymphoma across all extranodal sites. Bendamustine with rituximab overcomes known poor prognosis features in extranodal… Click to show full abstract
Key Points Bendamustine with rituximab is a highly effective frontline therapy in extranodal marginal zone lymphoma across all extranodal sites. Bendamustine with rituximab overcomes known poor prognosis features in extranodal marginal zone lymphoma.
Keywords:
international analysis;
bendamustine rituximab;
extranodal marginal;
marginal zone;
zone lymphoma
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!